CareDx Quarterly Income Statement
NASDAQ: CDNAHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CareDx revenue and earnings
In the quarter ended Jun 30, 2026, CareDx generated $131.9 million in revenue, up 52.2% from the same quarter a year earlier. Net income was $110.6 million, for a net margin of 83.8% versus a median of -3.8% in the prior 5 quarters. Operating margin was 85.8%.
Diluted earnings per share came in at $2.07.
Summary generated from market data by MetaCap's automated system. Methodology
CareDx income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 131.95M | 117.70M | 108.39M | 100.06M | 86.68M | 84.69M | 86.58M | 82.88M | 92.27M | 72.05M | 65.57M | 67.19M |
| Revenue growth (YoY) | +52.23% | +38.99% | +25.19% | +20.72% | -6.06% | +17.54% | +32.04% | +23.35% | +31.26% | -6.75% | -20.41% | -15.33% |
| Operating Expenses | 18.73M | 116.50M | 114.43M | 100.30M | 97.80M | 98.06M | 2.20M | 96.60M | 99.60M | 94.61M | 188.20M | 95.97M |
| Research & Development | 22.38M | 21.42M | 19.31M | 16.77M | 16.83M | 18.52M | 16.62M | 17.49M | 19.69M | 18.71M | 18.83M | 19.00M |
| Selling, General & Admin | 74.35M | 60.86M | 59.61M | 52.88M | 51.96M | 45.76M | 53.69M | 51.55M | 51.91M | 49.97M | 48.24M | 52.44M |
| Operating Income | 113.22M | 1.20M | -6.04M | -246.00K | -11.12M | -13.37M | 84.38M | -13.72M | -7.33M | -22.57M | -122.63M | -28.78M |
| Other Income (Expense) | 1.29M | 1.58M | 2.28M | 1.91M | 2.44M | 3.08M | 3.49M | 3.28M | 2.73M | 2.60M | 4.70M | 5.22M |
| Pretax Income | 114.52M | 2.78M | -3.76M | 1.66M | -8.69M | -10.29M | 87.87M | -10.44M | -4.60M | -19.97M | -117.93M | -23.57M |
| Income Tax | 3.88M | -32.01K | 345.00K | -15.00K | -117.00K | 58.00K | 171.00K | 200.00K | 22.00K | -83.00K | 165.00K | -80.00K |
| Net Income | 110.64M | 2.81M | -4.11M | 1.68M | -8.57M | -10.35M | 87.70M | -10.64M | -4.62M | -19.89M | -118.10M | -23.48M |
| Net Income growth (YoY) | — | — | -104.68% | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | 2.15 | 0.05 | -0.08 | 0.03 | -0.16 | -0.19 | 1.67 | -0.20 | -0.09 | -0.38 | -2.21 | -0.43 |
| EPS (Diluted) | 2.07 | 0.05 | -0.08 | 0.03 | -0.16 | -0.19 | 1.60 | -0.20 | -0.09 | -0.38 | -2.21 | -0.43 |
| Shares Outstanding (Basic) | 51.47M | 51.15M | — | 52.51M | 54.30M | 55.26M | — | 52.90M | 52.20M | 51.69M | — | 54.18M |
| Shares Outstanding (Diluted) | 53.42M | 53.13M | — | 53.74M | 54.30M | 55.26M | — | 52.90M | 52.20M | 51.69M | — | 54.18M |
| EBITDA | 116.03M | 5.10M | -2.16M | 3.57M | -7.40M | -9.77M | 87.74M | -10.25M | -3.78M | -18.75M | -119.00M | -25.12M |
| Operating Margin | 85.81% | 102.00% | -5.57% | -25.00% | -12.83% | -15.79% | 97.46% | -16.55% | -7.94% | -31.32% | -187.03% | -42.84% |
| Net Margin | 83.85% | 2.39% | -3.79% | 1.67% | -9.88% | -12.23% | 101.29% | -12.83% | -5.01% | -27.60% | -180.11% | -34.95% |
This table shows 12 quarterly periods of CareDx's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CDNA's reporting calendar. What is a income statement?